#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glomerulonephritis minimal lesion Parkinson's disease Thrombotic microangiopathy Hairy cell leukaemia recurrent Head and neck cancer Hepatobiliary cancer Meningococcal immunisation Chondrosarcoma Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Cutaneous lupus erythematosus Neoplasm Extra-osseous Ewing's sarcoma recurrent Granulomatosis with polyangiitis Waldenstrom's macroglobulinaemia recurrent Brain injury More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome Myxofibrosarcoma – Treatment Pulmonary sarcoidosis Chondrosarcoma metastatic – Diagnostics Marginal zone lymphoma – Life with Disease Acquired haemophilia – Diagnostics Medulloblastoma Ehlers-Danlos syndrome – Life with Disease Phenylketonuria – Trials in Disease Familial amyotrophic lateral sclerosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Skb264 NVG-2089 Fostemsavir Trometamol Digitoxin Dsimc Atorvastatin Calcium Anhydrous Cholestyramine Liquid Paraffin OXYBUTYNIN HYDROCHLORIDE Nadunolimab TEDUGLUTIDE Vx-522 Regn5668 Ivermectin Ramipril Iph5201 Atropine Sulfate Monohydrate LTI-03 Olanzapine Hydrocortisone Acetate More therapies…

    Learn about Your Condition

    Mechanical ventilation Muscular dystrophy Corneal dystrophy Colorectal cancer stage IV Methylmalonic acidaemia Perinatal depression Coronary artery dissection Chondroplasty Anogenital dysplasia Cortical dysplasia Prostate cancer metastatic Small cell carcinoma Embolism Coronary artery bypass Pyrexia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A study to evaluate the effect of allogeneic faecal microbiota on the core symptoms of autism spectrum disorder in children

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Autism spectrum disorder
    Investigated Drugs:
    • Allogeneic Faecal Microbiota
    Czechia

  • A study to compare using a half dose of iomeprol versus a standard dose of iomeprol for imaging lung tumors with spectral CT scans.

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Iomeprol
    Spain

  • A study to evaluate if hydrocortisone helps reduce symptoms of post-traumatic stress disorder in patients after exposure to a traumatic event.

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Post-traumatic stress disorder
    Investigated Drugs:
    • Hydrocortisone
    The Netherlands

  • A study to evaluate the safety and effectiveness of ADX-038 in adults with geographic atrophy caused by age-related macular degeneration.

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • ADX-038
    • Sodium Chloride
    Germany Italy Portugal Spain

  • Study to evaluate the efficacy and safety of liposomal amphotericin B for patients with simple pulmonary aspergilloma

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Amphotericin B
    Latvia

  • Study of the effect of lyophilized bacterial lysates on reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD)

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Hungary
Previous Page
1 … 733 734 735 736 737 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!